USPTO Wants Fed. Circ. To Rethink Cancer Patent App Ruling
The U.S. Patent and Trademark Office wants the Federal Circuit to rethink its decision reviving ImmunoGen's application for a patent on a cancer treatment, filing a petition at a time when...To view the full article, register now.
Already a subscriber? Click here to view full article